Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'WALDMANN TA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 106 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Waldmann, TA; Dubois, S; Tagaya, Y
      Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: Implications for immunotherapy

      IMMUNITY
    2. White, JD; Wharfe, G; Stewart, DM; Maher, VE; Eicher, D; Herring, B; Derby, M; Jackson-Booth, PG; Marshall, M; Lucy, D; Jain, A; Cranston, B; Hanchard, B; Lee, CC; Top, LE; Fleisher, TA; Nelson, DL; Waldmann, TA
      The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia/lymphoma

      LEUKEMIA & LYMPHOMA
    3. Yordanov, AT; Garmestani, K; Zhang, M; Zhang, Z; Yao, Z; Phillips, KE; Herring, B; Horak, E; Beitzel, MP; Schwarz, UP; Gansow, OA; Plascjak, PS; Eckelman, WC; Waldmann, TA; Brechbiel, MW
      Preparation and in vivo evaluation of linkers for At-211 labeling of humanized anti-Tac

      NUCLEAR MEDICINE AND BIOLOGY
    4. Yao, ZS; Garmestani, K; Wong, KJ; Park, LS; Dadachova, E; Yordanov, A; Waldmann, TA; Eckelman, WC; Paik, CH; Carrasquillo, JA
      Comparative cellular catabolism and retention of astatine-, bismuth-, and lead-radiolabeled internalizing monoclonal antibody

      JOURNAL OF NUCLEAR MEDICINE
    5. Perera, LP; Goldman, CK; Waldmann, TA
      Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    6. Azimi, N; Nagai, M; Jacobson, S; Waldmann, TA
      IL-15 plays a major role in the persistence of tax-specific CD8 cells in HAM/TSP patients

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    7. Baldassarre, G; Fedele, M; Battista, S; Vecchione, A; Klein-Szanto, AJP; Santoro, M; Waldmann, TA; Azimi, N; Croce, CM; Fusco, A
      Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    8. Perera, LP; Goldman, CK; Waldmann, TA
      Comparative assessment of virulence of recombinant vaccinia viruses expressing IL-2 and IL-15 in immunodeficient mice (vol 98, pg 5146, 2001)

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    9. Gaspar, R; Bagossi, P; Bene, L; Matko, J; Szollosi, J; Tozser, J; Fesus, L; Waldmann, TA; Damjanovich, S
      Clustering of class IHLA oligomers with CD8 and TCR: Three-dimensional models based on fluorescence resonance energy transfer and crystallographic data

      JOURNAL OF IMMUNOLOGY
    10. Mariner, JM; Lantz, V; Waldmann, TA; Azimi, N
      Human T cell lymphotropic virus type I tax activates IL-15R alpha gene expression through an NF-kappa B site

      JOURNAL OF IMMUNOLOGY
    11. Alileche, A; Goldman, CK; Waldmann, TA
      Differential effects of IL-2 and IL-15 on expression of IL-2 receptor alpha

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    12. Mandler, R; Dadachova, E; Brechbiel, JK; Waldmann, TA; Brechbiel, MW
      Synthesis and evaluation of antiproliferative activity of a geldanamycin-Herceptin (TM) immunoconjugate

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    13. Waldmann, TA
      T-cell receptors for cytokines: Targets for immunotherapy of leukemia/lymphoma

      ANNALS OF ONCOLOGY
    14. Azimi, N; Mariner, J; Jacobson, S; Waldmann, TA
      How does interleukin 15 contribute to the pathogenesis of HTLV type 1-associated myelopathy/tropical spastic paraparesis?

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    15. Kreitman, RJ; Wilson, WH; White, JD; Stetler-Stevenson, M; Jaffe, ES; Giardina, S; Waldmann, TA; Pastan, I
      Phase I trial of recombinant immunotoxin anti-Tac(Fv)PE38 (LMB-2) in patients with hematologic malignancies

      JOURNAL OF CLINICAL ONCOLOGY
    16. Yordanov, AT; Deal, K; Garmestani, K; Kobayashi, H; Herring, B; Waldmann, TA; Brechbiel, MW
      Synthesis and biodistribution study of a new At-211-calix[4]arene complex

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    17. Marks-Konczalik, J; Dubois, S; Losi, JM; Sabzevari, H; Yamada, N; Feigenbaum, L; Waldmann, TA; Tagaya, Y
      IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    18. Vereb, G; Matko, J; Vamosi, G; Ibrahim, SM; Magyar, E; Varga, S; Szollosi, J; Jenei, A; Gaspar, R; Waldmann, TA; Damjanovich, S
      Cholesterol-dependent clustering of IL-2R alpha and its colocalization with HLA and CD48 on T lymphoma cells suggest their functional association with lipid rafts

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    19. Azimi, N; Tagaya, Y; Mariner, J; Waldmann, TA
      Viral activation of interleukin-15 (IL-15): Characterization of a virus-inducible element in the IL-15 promoter region

      JOURNAL OF VIROLOGY
    20. Kurys, G; Tagaya, Y; Bamford, R; Hanover, JA; Waldmann, TA
      The long signal peptide isoform and its alternative processing direct the intracellular trafficking of interleukin-15

      JOURNAL OF BIOLOGICAL CHEMISTRY
    21. Phillips, KE; Herring, B; Wilson, LA; Rickford, MS; Zhang, ML; Goldman, CK; Tso, JY; Waldmann, TA
      IL-2R alpha-directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade ofIL-2/IL-2R alpha interaction

      CANCER RESEARCH
    22. Kobayashi, H; Carrasquillo, JA; Paik, CH; Waldmann, TA; Tagaya, Y
      Differences of biodistribution, pharmacokinetics, and tumor targeting between interleukins 2 and 15

      CANCER RESEARCH
    23. Morris, JC; Waldmann, TA
      Advances in interleukin 2 receptor targeted treatment

      ANNALS OF THE RHEUMATIC DISEASES
    24. Mandler, R; Wu, CC; Sausville, EA; Roettinger, AJ; Newman, DJ; Ho, DK; King, CR; Yang, DJ; Lippman, ME; Landolfi, NF; Dadachova, E; Brechbiel, MW; Waldmann, TA
      Immunoconjugates of geldanamycin and anti-HER2 monoclonal antibodies: Antiproliferative activity on human breast carcinoma cell lines

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    25. Kobayashi, H; Tagaya, Y; Han, ES; Kim, IS; Le, N; Paik, CH; Pastan, I; Nelson, DL; Waldmann, TA; Carrasquillo, JA
      Use of an antibody against the soluble interleukin 2 receptor alpha subunit can modulate the stability and biodistribution of interleukin 2

      CYTOKINE
    26. Waldmann, TA; Tagaya, Y
      The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens

      ANNUAL REVIEW OF IMMUNOLOGY
    27. Kobayashi, H; Sun, BF; Yoo, TM; Le, N; Kim, MK; Paik, CH; Pastan, I; Waldmann, TA; Carrasquillo, JA
      Methods to avoid adverse effect of circulating antigen on biodistribution of I-125-labeled antiTac dsFv: Preinjection of intact antibody versus clearance of antigen with avidin-biotin system

      JOURNAL OF NUCLEAR MEDICINE
    28. Kobayashi, H; Kim, IS; Drumm, D; Kim, MK; Paik, DS; Le, N; Waldmann, TA; Carrasquillo, JA; Paik, CH
      Favorable effects of glycolate conjugation on the biodistribution of humanized antiTac Fab fragment

      JOURNAL OF NUCLEAR MEDICINE
    29. Carrasquillo, JA; White, JD; Paik, CH; Raubitschek, A; Le, N; Rotman, M; Brechbiel, MW; Gansow, OA; Top, LE; Perentesis, P; Reynolds, JC; Nelson, DL; Waldmann, TA
      Similarities and differences in In-111- and Y-90-labeled 1B4M-DTPA antiTacmonoclonal antibody distribution

      JOURNAL OF NUCLEAR MEDICINE
    30. Nussenblatt, RB; Fortin, E; Schiffman, R; Rizzo, L; Smith, J; Van Veldhisen, P; Sran, P; Yaffe, A; Goldman, CK; Waldmann, TA; Whitcup, SM
      Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    31. Azimi, N; Jacobson, S; Leist, T; Waldmann, TA
      Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: Implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor

      JOURNAL OF IMMUNOLOGY
    32. Perera, LP; Goldman, CK; Waldmann, TA
      IL-15 induces the expression of chemokines and their receptors in T lymphocytes

      JOURNAL OF IMMUNOLOGY
    33. Kobayashi, H; Le, N; Kim, IS; Kim, MG; Pie, JE; Drumm, D; Paik, DS; Waldmann, TA; Paik, CH; Carrasquillo, JA
      The pharmacokinetic characteristics of glycolated humanized anti-Tac Fabs are determined by their isoelectric points

      CANCER RESEARCH
    34. Kreitman, RJ; Wilson, WH; Robbins, D; Margulies, I; Stetler-Stevenson, M; Waldmann, TA; Pastan, I
      Responses in refractory hairy cell leukemia to a recombinant immunotoxin

      BLOOD
    35. MANDLER R; LEVITZKI A; ROETTINGER AJ; GAZIT A; RAKHLIN YY; WALDMANN TA
      THE TYRPHOSTIN AG494 REDUCES IL2-INDUCED ACTIVATION OF JAK3 AND INHIBITS PROLIFERATION OF HUMAN LEUKEMIA-CELLS

      European cytokine network
    36. SCHWARZ UP; PLASCJAK P; BEITZEL MP; GANSOW OA; ECKELMAN WC; WALDMANN TA
      PREPARATION OF AT-211-LABELED HUMANIZED ANTI-TAC USING AT-211 PRODUCED IN DISPOSABLE INTERNAL AND EXTERNAL BISMUTH TARGETS

      Nuclear medicine and biology
    37. WALDMANN TA; OSHEA J
      THE USE OF ANTIBODIES AGAINST THE IL-2 RECEPTOR IN TRANSPLANTATION

      Current opinion in immunology
    38. KOBAYASHI H; SUN BF; HAN ES; KIM MK; LE N; WANG QC; NELSON DL; PASTAN I; WALDMANN TA; PAIK CH; CARRASQUILLO JA
      EPITOPE BLOCKING - POSITIVE AND NEGATIVE EFFECTS ON THE BIODISTRIBUTION OF I-125 LABELED ANTI-TAC DISULFIDE-STABILIZED FV FRAGMENT OF 2 ANTIBODIES AGAINST DIFFERENT EPITOPES OF THE CIRCULATING ANTIGEN

      Japanese journal of cancer research
    39. LOSI JM; OGASAWARA K; TANIGUCHI T; TAKI S; WALDMANN TA; TAGAYA Y
      IL-15 - A SEEMINGLY INDISPENSABLE FACTOR FOR BONE-MARROW-DERIVED NK CELL MATURATION

      The FASEB journal
    40. AZIMI N; BROWN K; BAMFORD RN; TAGAYA Y; SIEBENLIST U; WALDMANN TA
      HTLV-I TAX PROTEIN TRANS-ACTIVATES IL-15 GENE-TRANSCRIPTION THROUGH NF-KB IN HTLV-I INFECTED

      The FASEB journal
    41. KINGSBURY GA; WALDMANN TA; JUNGHANS RP
      EXAMINATION OF A ROLE FOR IDIOTYPY IN THE DISEASE REMISSION OF A LONG-TERM SURVIVOR ADULT T-CELL LEUKEMIA TREATED WITH ANTI-TAC ANTIBODY

      Leukemia
    42. Lehky, TJ; Levin, MC; Kubota, R; Bamford, RN; Flerlage, AN; Soldan, SS; Leist, TP; Xavier, A; White, JD; Brown, M; Fleisher, TA; Top, LE; Light, S; McFarland, HF; Waldmann, TA; Jacobson, S
      Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac

      ANNALS OF NEUROLOGY
    43. KIM MK; PIE JE; KOBAYASHI H; LE N; PAIK DS; WALDMANN TA; CARRASQUILLO JA; PAIK CH
      RENAL UPTAKE OF F(AB')2 CAN BE DECREASED BY LOWERING OF ITS PI BY ACYLATION WITH GLYCOLATE

      The Journal of nuclear medicine
    44. KOBAYASHI H; WU C; KIM MK; PAIK CH; WALDMANN TA; CARRASQUILLO JA; BRECHBIEL MW
      EVALUATION OF THE BIODISTRIBUTION OF IN-111 AND Y-88 LABELED DENDRIMER-1B4M-DTPA ALONE OR CONJUGATED WITH A MONOCLONAL-ANTIBODY

      The Journal of nuclear medicine
    45. OGASAWARA K; HIDA S; AZIMI N; TAGAYA Y; SATO T; YOKOCHIFUKUDA T; WALDMANN TA; TANIGUCHI T; TAKI S
      REQUIREMENT FOR IRF-1 IN THE MICROENVIRONMENT SUPPORTING DEVELOPMENT OF NATURAL-KILLER-CELLS (VOL 391, PG 700, 1998)

      Nature
    46. OGASAWARA K; HIDA S; AZIMI N; TAGAYA Y; SATO T; YOKOCHIFUKUDA T; WALDMANN TA; TANIGUCHI T; TAKI S
      REQUIREMENT FOR IRF-1 IN THE MICROENVIRONMENT SUPPORTING DEVELOPMENT OF NATURAL-KILLER-CELLS

      Nature
    47. MIGONE TS; CACALANO NA; TAYLOR N; YI TL; WALDMANN TA; JOHNSTON JA
      RECRUITMENT OF SH2-CONTAINING PROTEIN-TYROSINE-PHOSPHATASE SHP-1 TO THE INTERLEUKIN-2 RECEPTOR - LOSS OF SHP-1 EXPRESSION IN HUMAN T-LYMPHOTROPIC VIRUS TYPE I-TRANSFORMED T-CELLS

      Proceedings of the National Academy of Sciences of the United Statesof America
    48. AZIMI N; BROWN K; BAMFORD RN; TAGAYA Y; SIEBENLIST U; WALDMANN TA
      HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I TAX PROTEIN TRANS-ACTIVATES INTERLEUKIN-15 GENE-TRANSCRIPTION THROUGH AN NF-KAPPA-B SITE

      Proceedings of the National Academy of Sciences of the United Statesof America
    49. JUNGHANS RP; CARRASQUILLO JA; WALDMANN TA
      IMPACT OF ANTIGENEMIA ON THE BIOACTIVITY OF INFUSED ANTI-TAC ANTIBODY- IMPLICATIONS FOR DOSE SELECTION IN ANTIBODY IMMUNOTHERAPIES

      Proceedings of the National Academy of Sciences of the United Statesof America
    50. PERERA LP; WALDMANN TA
      ACTIVATION OF HUMAN MONOCYTES INDUCES DIFFERENTIAL RESISTANCE TO APOPTOSIS WITH RAPID DOWN-REGULATION OF CASPASE-8 FLICE/

      Proceedings of the National Academy of Sciences of the United Statesof America
    51. EICHER DM; WALDMANN TA
      IL-2R-ALPHA ON ONE-CELL CAN PRESENT IL-2 TO IL-2R-BETA GAMMA(C) ON ANOTHER CELL TO AUGMENT IL-2 SIGNALING/

      The Journal of immunology (1950)
    52. BAMFORD RN; DEFILIPPIS AP; AZIMI N; KURYS G; WALDMANN TA
      THE 5'-UNTRANSLATED-REGION, SIGNAL PEPTIDE, AND THE CODING SEQUENCE OF THE CARBOXYL-TERMINUS OF IL-15 PARTICIPATE IN ITS MULTIFACETED TRANSLATIONAL CONTROL

      The Journal of immunology
    53. KOBAYASHI H; SUN BF; YOO TM; KIM MK; LE N; WANG QC; PASTAN I; WALDMANN TA; PAIK CH; CARRASQUILLO JA
      COMPARISON OF 2 METHODS TO AVOID THE ADVERSE-EFFECTS OF CIRCULATING ANTIGEN ON BIODISTRIBUTION OF I-125 ANTI-TAC DSFV - PREINJECTION OF IGGVS CLEARANCE OF ANTIGEN WITH AVIDIN-BIOTIN SYSTEM

      The Journal of nuclear medicine
    54. KOBAYASHI H; SUN BF; YOO TM; HUN ES; KIM MK; LE N; WANG QC; NELSON DL; PASTAN L; WALDMANN TA; PAIK CH; CARRASQUILLO JA
      EPITOPE COATING OF CIRCULATING ANTIGEN - POSITIVE AND NEGATIVE EFFECTOF 2 ANTIBODIES RECOGNIZING DIFFERENT EPITOPES OF THE ALPHA-SUBUNIT OF THE IL-2 RECEPTOR ON THE BIODISTRIBUTION OF I-125 ANTI-TAC DSFV

      The Journal of nuclear medicine
    55. HORAK E; HARTMANN F; GARMESTANI K; WU CC; BRECHBIEL M; GANSOW OA; LANDOLFI NF; WALDMANN TA
      RADIOIMMUNOTHERAPY TARGETING OF HER2 NEU ONCOPROTEIN ON OVARIAN TUMORUSING LEAD-212-DOTA-AE1/

      The Journal of nuclear medicine
    56. RICHARDSON JH; WALDMANN TA; SODROSKI JG; MARASCO WA
      INDUCIBLE KNOCKOUT OF THE INTERLEUKIN-2 RECEPTOR-ALPHA CHAIN - EXPRESSION OF THE HIGH-AFFINITY IL-2 RECEPTOR IS NOT REQUIRED FOR THE IN-VITRO GROWTH OF HTLV-I-TRANSFORMED CELL-LINES

      Virology
    57. TAGAYA Y; KURYS G; THIES TA; LOSI JM; AZIMI N; HANOVER JA; BAMFORD RN; WALDMANN TA
      GENERATION OF SECRETABLE AND NONSECRETABLE INTERLEUKIN-15 ISOFORMS THROUGH ALTERNATE USAGE OF SIGNAL PEPTIDES

      Proceedings of the National Academy of Sciences of the United Statesof America
    58. DAMJANOVICH S; BENE L; MATKO J; ALILECHE A; GOLDMAN CK; SHARROW S; WALDMANN TA
      PREASSEMBLY OF INTERLEUKIN-2 (IL-2) RECEPTOR SUBUNITS ON RESTING KIT-225 K6 T-CELLS AND THEIR MODULATION BY IL-2, IL-7, AND IL-15 - A FLUORESCENCE RESONANCE ENERGY-TRANSFER STUDY

      Proceedings of the National Academy of Sciences of the United Statesof America
    59. GUEXCROSIER Y; RABER J; CHAN CC; KRIETE MS; BENICHOU J; PILSON RS; KERWIN JA; WALDMANN TA; HAKIMI J; ROBERGE FG
      HUMANIZED ANTIBODIES AGAINST THE ALPHA-CHAIN OF THE IL-2 RECEPTOR ANDAGAINST THE BETA-CHAIN SHARED BY THE IL-2 AND IL-15 RECEPTORS IN A MONKEY UVEITIS MODEL OF AUTOIMMUNE-DISEASES

      The Journal of immunology
    60. HARTMANN F; HORAK EM; CHO C; LUPU R; BOLEN JB; STETLERSTEVENSON MA; PFREUNDSCHUH M; WALDMANN TA; HORAK ID
      EFFECTS OF THE TYROSINE-KINASE INHIBITOR GELDANAMYCIN ON LIGAND-INDUCED HER-2 NEU ACTIVATION, RECEPTOR EXPRESSION AND PROLIFERATION OF HER-2-POSITIVE MALIGNANT-CELL LINES/

      International journal of cancer
    61. ROSEN FS; WEDGWOOD RJP; EIBL M; FISCHER A; AIUTI F; NOTARANGELO L; KISHIMOTO T; RESNICK IB; HAMMARSTROM L; SEGER R; CHAPEL H; THOMPSON RA; COOPER MD; GEHA RS; GOOD RA; WALDMANN TA
      PRIMARY IMMUNODEFICIENCY DISEASES

      Clinical and experimental immunology
    62. KOBAYASHI H; YOO TM; DRUMM D; KIM MK; SUN BF; LE N; WEBBER KO; PASTAN I; WALDMANN TA; PAIK CH; CARRASQUILLO JA
      IMPROVED BIODISTRIBUTION OF I-125 LABELED ANTI-TAC DISULFIDE-STABILIZED FV FRAGMENT BY BLOCKING ITS BINDING TO THE ALPHA-SUBUNIT OF THE INTERLEUKIN-2 RECEPTOR IN THE CIRCULATION WITH PREINJECTED HUMANIZED ANTI-TAC IGG

      Cancer research
    63. KREITMAN RJ; WHITE JD; PEARSON D; TOP LE; WALDMANN TA; PASTAN I
      PHASE-I CLINICAL-TRIAL OF RECOMBINANT IMMUNOTOXIN ANTI-TAC(FV)-PE38 (LMB-2) IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES

      Blood
    64. TAGAYA Y; BURTON JD; MIYAMOTO Y; WALDMANN TA
      INTERLEUKIN-15 T IS A NOVEL GROWTH-FACTOR FOR MAST-CELLS/

      Journal of investigative medicine
    65. WALDMANN TA
      THE PROMISCUOUS IL-2 IL-15 RECEPTOR - A TARGET FOR IMMUNOTHERAPY OF HTLV-I-ASSOCIATED DISORDERS/

      Journal of acquired immune deficiency syndromes and human retrovirology
    66. TAGAYA Y; BAMFORD RN; DEFILIPPIS AP; WALDMANN TA
      IL-15 - A PLEIOTROPIC CYTOKINE WITH DIVERSE RECEPTOR SIGNALING PATHWAYS WHOSE EXPRESSION IS CONTROLLED AT MULTIPLE LEVELS/

      Immunity
    67. WHITE JD; JOHNSON JA; NAM JM; CRANSTON B; HANCHARD B; WALDMANN TA; MANNS A
      DISTRIBUTION OF HUMAN-LEUKOCYTE ANTIGENS IN A POPULATION OF BLACK PATIENTS WITH HUMAN T-CELL LYMPHOTROPHIC VIRUS TYPE I-ASSOCIATED ADULT T-CELL LEUKEMIA LYMPHOMA/

      Cancer epidemiology, biomarkers & prevention
    68. TAGAYA Y; BURTON JD; MIYAMOTO Y; WALDMANN TA
      INTERLEUKIN-15 T UTILIZES A NOVEL RECEPTOR SIGNAL-TRANSDUCTION PATHWAY IN MAST-CELLS/

      The FASEB journal
    69. BAMFORD RN; BATTIATA AP; WALDMANN TA
      IL-15 - THE ROLE OF TRANSLATIONAL REGULATION IN THEIR EXPRESSION

      Journal of leukocyte biology
    70. TAGAYA Y; BURTON JD; MIYAMOTO Y; WALDMANN TA
      IDENTIFICATION OF A NOVEL RECEPTOR SIGNAL-TRANSDUCTION PATHWAY FOR IL-15 T IN MAST-CELLS/

      EMBO journal
    71. CARRASQUILLO JA; WHITE JD; PAIK CH; LE N; ROTMAN M; GOLDMAN CK; BRECHBIEL MW; GANSOW OA; TOP LE; REYNOLDS JC; NELSON DL; WALDMANN TA
      BIODISTRIBUTION OF IN-111 VS Y-90 LABELED ANTI-TAC MONOCLONAL-ANTIBODY

      The Journal of nuclear medicine
    72. BAMFORD RN; BATTIATA AP; BURTON JD; SHARMA H; WALDMANN TA
      INTERLEUKIN (IL)-15 IL-T PRODUCTION BY THE ADULT T-CELL LEUKEMIA-CELLLINE HUT-102 IS ASSOCIATED WITH A HUMAN T-CELL LYMPHOTROPHIC VIRUS TYPE-I-R REGION/IL-15 FUSION MESSAGE THAT LACKS MANY UPSTREAM AUGS THAT NORMALLY ATTENUATE IL-15 MESSENGER-RNA TRANSLATION/

      Proceedings of the National Academy of Sciences of the United Statesof America
    73. JUNGHANS RP; WALDMANN TA
      METABOLISM OF TAC (IL2R-ALPHA) - PHYSIOLOGY OF CELL-SURFACE SHEDDING AND RENAL CATABOLISM, AND SUPPRESSION OF CATABOLISM BY ANTIBODY-BINDING

      The Journal of experimental medicine
    74. RICHARDSON JH; ZANI C; SODROSKI JG; WALDMANN TA; MARASCO WA
      PHENOTYPIC KNOCKOUT OF THE INTERLEUKIN-2 RECEPTOR IN HTLV-I TRANSFORMED-CELL LINES

      Journal of acquired immune deficiency syndromes and human retrovirology
    75. WALDMANN TA
      THE PROMISCUOUS IL-2 RECEPTOR - A TARGET FOR IMMUNOTHERAPY OF HTLV-I-ASSOCIATED DISEASES

      Journal of acquired immune deficiency syndromes and human retrovirology
    76. BAMFORD RN; BATTIATA AP; WALDMANN TA
      IL-1S IL-T PRODUCTION BY HUT-102 CELLS IS ASSOCIATED WITH AN HTLV-I-R/IL-15 FUSION MESSAGE THAT LACKS MANY UPSTREAM AUGS THAT NORMALLY ATTENUATE IL-15 MESSENGER-RNA TRANSLATION/

      AIDS research and human retroviruses
    77. WALDMANN TA
      THE METABOLISM BRANCH - AN EXEMPLAR OF PATIENT-ORIENTED RESEARCH

      Cancer investigation
    78. WALDMANN TA
      HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I ASSOCIATED ADULT T-CELL LEUKEMIA - THE JOSEPH-GOLDBERGER-CLINICAL-INVESTIGATOR-LECTURE

      JAMA, the journal of the American Medical Association
    79. RICHARDSON JH; SODROSKI JG; WALDMANN TA; MARASCO WA
      PHENOTYPIC KNOCKOUT OF THE HIGH-AFFINITY HUMAN INTERLEUKIN-2 RECEPTORBY INTRACELLULAR SINGLE-CHAIN ANTIBODIES AGAINST THE ALPHA-SUBUNIT OFTHE RECEPTOR

      Proceedings of the National Academy of Sciences of the United Statesof America
    80. ROSEN FS; WEDGWOOD RJP; EIBL M; GRISCELLI C; SELIGMANN M; AIUTI F; KISHIMOTO T; MATSUMOTO S; REZNIK IB; HANSON LA; THOMPSON RA; COOPER MD; GEHA RS; GOOD RA; WALDMANN TA
      PRIMARY IMMUNODEFICIENCY DISEASES

      Clinical and experimental immunology
    81. WHITE JD; ZAKNOEN SL; KASTENSPORTES C; TOP LE; NAVARROROMAN L; NELSON DL; WALDMANN TA
      INFECTIOUS COMPLICATIONS AND IMMUNODEFICIENCY IN PATIENTS WITH HUMAN T-CELL LYMPHOTROPIC VIRUS I-ASSOCIATED ADULT T-CELL LEUKEMIA LYMPHOMA/

      Cancer
    82. WALDMANN TA; WHITE JD; CARRASQUILLO JA; REYNOLDS JC; PAIK CH; GANSOW OA; BRECHBIEL MW; JAFFE ES; FLEISHER TA; GOLDMAN CK; TOP LE; BAMFORD R; ZAKNOEN S; ROESSLER E; KASTENSPORTES C; ENGLAND R; LITOU H; JOHNSON JA; JACKSONWHITE T; MANNS A; HANCHARD B; JUNGHANS RP; NELSON DL
      RADIOIMMUNOTHERAPY OF INTERLEUKIN-2R-ALPHA-EXPRESSING ADULT T-CELL LEUKEMIA WITH YTTRIUM-90-LABELED ANTI-TAC

      Blood
    83. GALE RP; WALDMANN TA; ARMITAGE JO; CAVALLI F
      RECENT PROGRESS IN B-CELL AND T-CELL LYMPHOMAS

      Annals of oncology
    84. WALDMANN TA
      LYMPHOKINE RECEPTORS - A TARGET FOR IMMUNOTHERAPY OF LYMPHOMAS

      Annals of oncology
    85. TIFFANY LJ; DOBBS D; GARMESTANI K; RAUBITSCHEK A; TINUBU A; BRECHBIEL MW; GOFFMAN T; GANSOW OA; WALDMANN TA; KOZAK RW
      RADIOLABELED CHX(B)-2E4 IS STABLE IN-VIVO AND IS A SUITABLE IMMUNOCONJUGATE FOR TESTING ALPHA-PARTICLE-EMITTING BISMUTH RADIONUCLIDES IN INTERLEUKIN-2 RECEPTOR TARGETED IMMUNOTHERAPY

      Antibody immunoconjugates, and radiopharmaceuticals
    86. WALDMANN TA
      THE INTERLEUKIN-2 RECEPTOR - A TARGET FOR IMMUNOTHERAPY OF LEUKEMIA-LYMPHOMA

      Journal of cellular biochemistry
    87. HORAK E; HARTMANN F; GARMESTANI K; WU CC; GANSOW OA; LANDOLFI NF; WALDMANN TA
      RADIOIMMUNOTHERAPY OF NUDE-MICE BEARING A HUMAN HER2 NEU POSITIVE TUMOR UTILIZING THE ALPHA-EMITTING RADIONUCLIDE-CONJUGATED MONOCLONAL-ANTIBODY PB-212-DOTA-AE1/

      Journal of cellular biochemistry
    88. ROESSLER E; GRANT A; JU G; TSUDO M; SUGAMURA K; WALDMANN TA
      COOPERATIVE INTERACTIONS BETWEEN THE INTERLEUKIN-2 RECEPTOR-ALPHA ANDBETA-CHAINS ALTER THE INTERLEUKIN-2-BINDING AFFINITY OF THE RECEPTOR SUBUNITS

      Proceedings of the National Academy of Sciences of the United Statesof America
    89. BURTON JD; BAMFORD RN; PETERS C; GRANT AJ; KURYS G; GOLDMAN CK; BRENNAN J; ROESSLER E; WALDMANN TA
      A LYMPHOKINE, PROVISIONALLY DESIGNATED INTERLEUKIN-T AND PRODUCED BY A HUMAN ADULT T-CELL LEUKEMIA LINE, STIMULATES T-CELL PROLIFERATION AND THE INDUCTION OF LYMPHOKINE-ACTIVATED KILLER-CELLS

      Proceedings of the National Academy of Sciences of the United Statesof America
    90. BAMFORD RN; GRANT AJ; BURTON JD; PETERS C; KURYS G; GOLDMAN CK; BRENNAN J; ROESSLER E; WALDMANN TA
      THE INTERLEUKIN (IL)-2 RECEPTOR-BETA CHAIN IS SHARED BY IL-2 AND A CYTOKINE, PROVISIONALLY DESIGNATED IL-T, THAT STIMULATES T-CELL PROLIFERATION AND THE INDUCTION OF LYMPHOKINE-ACTIVATED KILLER-CELLS

      Proceedings of the National Academy of Sciences of the United Statesof America
    91. TINUBU SA; HAKIMI J; KONDAS JA; BAILON P; FAMILLETTI PC; SPENCE C; CRITTENDEN MD; PARENTEAU GL; DIRBAS FM; TSUDO M; BACHER JD; KASTENSPORTES C; MARTINUCCI JL; GOLDMAN CK; CLARK RE; WALDMANN TA
      HUMANIZED ANTIBODY-DIRECTED TO THE IL-2 RECEPTOR BETA-CHAIN PROLONGS PRIMATE CARDIAC ALLOGRAFT SURVIVAL

      The Journal of immunology
    92. BURTON JD; BAMFORD RN; PETERS C; GRANT AJ; KURYS G; GOLDMAN CK; BRENNAN J; ROESSLER E; WALDMANN TA
      A NOVEL CYTOKINE PROVISIONALLY TERMED IL-T THAT STIMULATES T-CELL ANDLAK ACTIVITY REQUIRES IL-2R-BETA FOR ITS ACTION

      Clinical research
    93. HARTMANN F; HORAK EM; GARMESTANI K; WU CC; BRECHBIEL MW; KOZAK RW; TSO J; KOSTEINY SA; GANSOW OA; NELSON DL; WALDMANN TA
      RADIOIMMUNOTHERAPY OF NUDE-MICE BEARING A HUMAN INTERLEUKIN-2 RECEPTOR ALPHA-EXPRESSING LYMPHOMA UTILIZING THE ALPHA-EMITTING RADIONUCLIDE-CONJUGATED MONOCLONAL-ANTIBODY BI-212-ANTI-TAC

      Cancer research
    94. TENDLER CL; BURTON JD; JAFFE J; DANIELPOUR D; CHARLEY M; MCCOY JP; PITTELKOW MR; WALDMANN TA
      ABNORMAL CYTOKINE EXPRESSION IN SEZARY AND ADULT T-CELL LEUKEMIA-CELLS CORRELATES WITH THE FUNCTIONAL DIVERSITY BETWEEN THESE T-CELL MALIGNANCIES

      Cancer research
    95. ANASETTI C; HANSEN JA; WALDMANN TA; APPELBAUM FR; DAVIS J; DEEG HJ; DONEY K; MARTIN PJ; NASH R; STORB R; SULLIVAN KM; WITHERSPOON RP; BINGER MH; CHIZZONITE R; HAKIMI J; MOULD D; SATOH H; LIGHT SE
      TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE WITH HUMANIZED ANTI-TAC - AN ANTIBODY THAT BINDS TO THE INTERLEUKIN-2 RECEPTOR

      Blood
    96. KASTENSPORTES C; ZAKNOEN S; STEIS RG; CHAN WC; WINTON EF; WALDMANN TA
      T-CELL RECEPTOR GENE REARRANGEMENT IN T-CELL LARGE GRANULAR LEUKOCYTELEUKEMIA - PREFERENTIAL-V-ALPHA BUT DIVERSE-J-ALPHA USAGE IN ONE OF 5PATIENTS

      Blood
    97. WALDMANN TA; GOLDMAN CK; TOP L; GANSOW O; KASTENSPORTES C; ROESSLER E; ZAKNOEN S; WHITE J; HORAK I; CARRASQUILLO JA; REYNOLDS JC; NELSON DL
      THE TREATMENT OF HTLV-I-ASSOCIATED ADULT T-CELL LEUKEMIA (ATL) WITH GENETICALLY ENGINEERED MONOCLONAL-ANTIBODIES ARMED WITH RADIONUCLIDES

      Journal of acquired immune deficiency syndromes
    98. KREITMAN RJ; CHAUDHARY VK; WALDMANN TA; HANCHARD B; CRANSTON B; FITZGERALD DJP; PASTAN I
      CYTOTOXIC ACTIVITIES OF RECOMBINANT IMMUNOTOXINS COMPOSED OF PSEUDOMONAS TOXIN OR DIPHTHERIA-TOXIN TOWARD LYMPHOCYTES FROM PATIENTS WITH ADULT T-CELL LEUKEMIA

      Leukemia
    99. WALDMANN TA
      1992 STOHLMAN MEMORIAL LECTURE - TARGETING THE IL-2 RECEPTOR

      Leukemia
    100. WALDMANN TA
      THE IL-2 IL-2 RECEPTOR SYSTEM - A TARGET FOR RATIONAL IMMUNE INTERVENTION/

      Immunology today


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 09:29:03